These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Different stimuli to disseminated intravascular coagulation in liver diseases. Liehr H; Gruen M; Thiel H Thromb Diath Haemorrh; 1972 Oct; 28(2):325-6. PubMed ID: 4639664 [No Abstract] [Full Text] [Related]
6. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine]. Reutter W; Bachmann W Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984 [No Abstract] [Full Text] [Related]
7. [Aggravation of acute galactosamine hepatitis by a sodic bicarbonated water in rats (author's transl)]. de La Tour J; Souchard M; Chariot J; Rozé C; Potet F; Vaille C J Pharmacol; 1981; 12(1):37-50. PubMed ID: 6261045 [TBL] [Abstract][Full Text] [Related]
8. ["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis]. Reutter W; Bauer C; Bachmann W; Lesch R Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):747. PubMed ID: 5069316 [No Abstract] [Full Text] [Related]
10. Protective role of prednisolone upon galactosamine-induced hepatitis in rats. Grases PJ; Reutter W; Lesch R G E N; 1972; 27(2):197-204. PubMed ID: 4201408 [No Abstract] [Full Text] [Related]
11. [Protective and curative effects of diethyldithiocarbamate on galactosamine hepatitis in the rat (author's transl)]. Homann J; Gerhardt H; Hopf F Arzneimittelforschung; 1980; 30(4):645-7. PubMed ID: 6249330 [TBL] [Abstract][Full Text] [Related]
12. [Lidocain clearance after oral and intravenous application in rats with low grade ANIT-cholestasis and galactosamine-induced hepatitis (author's transl)]. Fuchshofen M; Heusler H; Lutz B; Mora E; Richter E Z Gastroenterol; 1980 Aug; 18(8):436-42. PubMed ID: 7434856 [TBL] [Abstract][Full Text] [Related]
13. The effect of fasting on galactosamine induced hepatitis in experimental animals. Pickering RW Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109 [TBL] [Abstract][Full Text] [Related]
14. [Prevention of galactosamine hepatitis using administration of D-galactose: significance of temporally limited UDP-galactose deficit for the induction of galactosamine hepatitis]. Bauer C; Reutter W; Bachmann W; Lesch R Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1502. PubMed ID: 4649767 [No Abstract] [Full Text] [Related]
15. [Effect of essential phospholipids on the galactosamine hepatitis in rats]. Petzold H; Titlbach O Cesk Gastroenterol Vyz; 1974 Apr; 28(3):178-80. PubMed ID: 4447983 [No Abstract] [Full Text] [Related]
16. [Liver tissue enzymes in rats with galactosamine hepatitis during simultaneous administration of choline-orotate]. Petzold H Cesk Gynekol; 1973 Jul; 27(5):290-3. PubMed ID: 4269483 [No Abstract] [Full Text] [Related]
17. Changes in polyamine metabolism of rat liver after administration of D-galactosamine. Favorable effects of putrescine administration on galactosamine-induced hepatic injury. Daikuhara Y; Tamada F; Takigawa M; Takeda Y; Mori Y Gastroenterology; 1979 Jul; 77(1):123-32. PubMed ID: 447009 [TBL] [Abstract][Full Text] [Related]
18. Significance of endotoxaemia in experimental "galactosamine-hepatitis" in the rat. Grün M; Liehr H; Rasenack U Acta Hepatogastroenterol (Stuttg); 1977 Apr; 24(2):64-81. PubMed ID: 857560 [TBL] [Abstract][Full Text] [Related]
19. [Galactosamine-hepatitis and anit-cholestasis. Liver damage caused by D-galactosamine-hydrochloride and 1-naphthyl-isothiocyanate (anit)]. Leinweber B Fortschr Med; 1973 Jun; 91(18):792-6. PubMed ID: 4723864 [No Abstract] [Full Text] [Related]
20. [Role of endotoxins in renal changes during hepatopathies]. Liehr H; Grün M Minerva Med; 1978 Oct; 69(47):3231-42. PubMed ID: 362247 [No Abstract] [Full Text] [Related] [Next] [New Search]